135 related articles for article (PubMed ID: 31154422)
1. Optimal sampling of pelvic lymphadenectomy specimens following radical prostatectomy: is complete tissue submission justified?
Ni Mhaolcatha S; Power E; Mayer N; Prendeville S
J Clin Pathol; 2019 Oct; 72(10):712-715. PubMed ID: 31154422
[TBL] [Abstract][Full Text] [Related]
2. The Hunt for Lymph Nodes: Is Total Submission of Standard-Template and Extended-Template Pelvic Lymph Node Dissections Necessary for Detecting Metastatic Prostate Cancer?
Gafeer MM; Arriola AGP
Arch Pathol Lab Med; 2023 Dec; 147(12):1466-1470. PubMed ID: 36881767
[TBL] [Abstract][Full Text] [Related]
3. Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology.
Prendeville S; Berney DM; Bubendorf L; Compérat E; Egevad L; Hes O; Kristiansen G; Oxley J; van Leenders GJLH; Varma M; van der Kwast T
Histopathology; 2019 May; 74(6):844-852. PubMed ID: 30604878
[TBL] [Abstract][Full Text] [Related]
4. Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy.
Rais-Bahrami S; Tracht JP; McIntosh ER; Lai WS; Gordetsky JB
Int J Surg Pathol; 2017 Feb; 25(1):12-17. PubMed ID: 27388198
[TBL] [Abstract][Full Text] [Related]
5. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
[TBL] [Abstract][Full Text] [Related]
6. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
7. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of pelvic lymph node metastases in prostatic adenocarcinoma: a study of 83 cases.
Yoon JY; Kryvenko ON; Ghani KR; Bertucci C; Menon M; Gupta NS
Int J Surg Pathol; 2012 Oct; 20(5):449-54. PubMed ID: 22674913
[TBL] [Abstract][Full Text] [Related]
9. Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer.
Mandel P; Kriegmair MC; Bogdan K; Boehm K; Budäus L; Graefen M; Huland H; Tilki D
Eur Urol Focus; 2017 Apr; 3(2-3):248-255. PubMed ID: 28753755
[TBL] [Abstract][Full Text] [Related]
10. Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.
Sagalovich D; Calaway A; Srivastava A; Sooriakumaran P; Tewari AK
BJU Int; 2013 Jan; 111(1):85-94. PubMed ID: 22823452
[TBL] [Abstract][Full Text] [Related]
11. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
12. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
13. How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications.
Capitanio U; Pellucchi F; Gallina A; Briganti A; Suardi N; Salonia A; Abdollah F; Di Trapani E; Jeldres C; Cestari A; Karakiewicz PI; Montorsi F
BJU Int; 2011 Apr; 107(7):1095-101. PubMed ID: 20880192
[TBL] [Abstract][Full Text] [Related]
14. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
15. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
[TBL] [Abstract][Full Text] [Related]
16. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
17. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
Abdollah F; Briganti A; Montorsi F; Stenzl A; Stief C; Tombal B; Van Poppel H; Touijer K
Eur Urol; 2015 May; 67(5):839-49. PubMed ID: 24698524
[TBL] [Abstract][Full Text] [Related]
18. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
Heidenreich A; Ohlmann CH; Polyakov S
Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
[TBL] [Abstract][Full Text] [Related]
19. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
[TBL] [Abstract][Full Text] [Related]
20. The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate Cancer.
Mandel P; Kriegmair MC; Veleva V; Salomon G; Graefen M; Huland H; Tilki D
Urology; 2016 Jul; 93():141-6. PubMed ID: 26968487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
